MSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.
More Information Supplier PageMSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.
More Information Supplier PageMSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.
More Information Supplier PageMSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.
More Information Supplier PageAscomycin is a potent immunosuppressive agent that could be used as a potential therapeutic agent for autoimmune diseases.
More Information Supplier PageAscomycin is a potent immunosuppressive agent that could be used as a potential therapeutic agent for autoimmune diseases.
More Information Supplier PageAscomycin is a potent immunosuppressive agent that could be used as a potential therapeutic agent for autoimmune diseases.
More Information Supplier PageAscomycin is a potent immunosuppressive agent that could be used as a potential therapeutic agent for autoimmune diseases.
More Information Supplier PageAscomycin is a potent immunosuppressive agent that could be used as a potential therapeutic agent for autoimmune diseases.
More Information Supplier PageDapivirine is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI)
More Information Supplier Page
